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Optical contrast agents have been widely applied to enhance the sensitivity and specificity of optical imaging
with near-infrared (NIR) light. However, because of the overwhelming scattering of light in biological tis-
sues, the spatial resolution of traditional optical imaging degrades drastically as the imaging depth increases.
Here, for the first time to our knowledge, we present noninvasive photoacoustic angiography of animal brains
in vivo with NIR light and an optical contrast agent. When indocyanine green polyethylene glycol, a novel ab-
sorption dye with prolonged clearance, is injected into the circulatory system of a rat, it obviously enhances the
absorption contrast between the blood vessels and the background tissues. Because NIR light can penetrate
deep into the brain tissues through the skin and skull, we are able to successfully reconstruct the vascular
distribution in the rat brain from the photoacoustic signals. On the basis of differential optical absorption
with and without contrast enhancement, a photoacoustic angiograph of a rat brain is acquired that matches
the anatomical photograph well and exhibits high spatial resolution and a much-reduced background. This
new technology demonstrates the potential for dynamic and molecular biomedical imaging. © 2004 Optical
Society of America
OCIS codes: 170.5120, 170.3880, 170.0110, 170.1470.The high sensitivity of optical imaging modalities
aided by contrast agents parallels that of nuclear
imaging and allows the visualization of organs such as
the brain without the undesirable effect of ionizing ra-
diation. Indocyanine dyes, with strong absorption in
the near-infrared (NIR) spectra, are especially useful
because NIR light has low absorption in biological tis-
sues and consequently has relatively deep penetration.
For example, indocyanine green (ICG), which has
been approved by the Food and Drug Administration,
in combination with NIR techniques, is employed
widely in clinical applications such as cardiac output
monitoring,1 hepatic function study,2 angiography
in ophthalmology,3 and tumor detection.4 However,
because of the strong scattering nature of biological
tissues in NIR, pure optical imaging techniques,
whether diffuse optical tomography, f luorescence
imaging, or other microscopies, cannot provide high
spatial resolution beyond the skin. The photoacoustic
imaging technique, which has the merits of both light
and ultrasound, has been proved to be a powerful0146-9592/04/070730-03$15.00/0tool for visualizing biological tissues with satisfactory
sensitivity and spatial resolution.5 – 10 In this study,
distributions of NIR absorption in biological tissues
that were modif ied by an optical contrast agent were
imaged with the photoacoustic modality. With this
technique we successfully achieved noninvasive photo-
acoustic angiography—mapping of the vasculature—
in the cortex of rat brains in vivo for what appears to
be the first time.
The setup for noninvasive photoacoustic angiogra-
phy of rat brains is shown in Fig. 1(A). A tunable
dye laser (ND6000, Continuum) pumped by a Nd:YAG
laser (Brilliant B, Bigsky) was employed to provide
laser pulses with a FWHM of 6.5 ns, a pulse repetition
rate of 10 Hz, and a wavelength of 805 nm. The inci-
dent energy density of the laser beam was controlled
to ,2 mJcm2 on the surface of the rat head, which in-
duced a temperature rise in the brain vessels estimated
to be ,2.6 mK. An unfocused ultrasonic transducer
(XMS-310, Panametrics) with a central frequency of
10.4 MHz, a bandwidth of 100% at 26 dB, and an© 2004 Optical Society of America
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raphy in the rat brain, employing an optical contrast agent
and a NIR laser. (B) Absorption spectra of ICG-PEG and
native ICG. (C) Intensity of the photoacoustic signals
from the blood vessels in the median f issure of the rat
brain as a function of time after the intravascular injection
of ICG-PEG (circles) or native ICG (triangles), which are
normalized to the initial intensity of the photoacoustic
signals before the injection. PA, photoacoustic.
active element of 2 mm in diameter was used to detect
the photoacoustic signals. The transducer was driven
by a computer-controlled step motor to scan around the
cortex of the rat brain in the x y plane with a radius
of 3 cm and a step size of 1.5±. The data acquisition
time for one image was 23.5 min.
The rat was fixed by use of a homemade mount with
its head protruding into the water tank through a hole
in the bottom of the tank where a piece of clear polyeth-
ylene film between the water and the rat head sealed
the hole. A thin layer of ultrasonic coupling gel was
applied on the surface of the rat head. The photo-
acoustic signals detected by the transducer were re-
ceived by an amplifier and then sent to an oscilloscope.
Finally, a computer collected the digitized signals to re-
construct the distribution of optical absorption in the
imaging plane through a modif ied backprojection algo-
rithm.11 Sprague Dawley rats (150 g, Charles River
Breeding Laboratories) were employed for the imagingexperiments. Before imaging, the hair on each rat’s
head was removed with hair remover lotion. A dose
of 87 mgkg Ketamine plus 13 mgkg Xylasine was ad-
ministered intramuscularly to anesthetize the rats dur-
ing the data acquisition.
The optical contrast agent was injected into the
circulatory system of the rats through the tail
vein. To prolong the circulation of ICG in blood,
polyethylene glycol (PEG),12 a polymer approved
by the Food and Drug Administration with the
structure -CH2CH2O-n, was adopted to stabilize
the ICG. This PEG conjugate of ICG (ICG-PEG)
with high optical absorption near the 805-nm wave-
length [see Fig. 1(B)] was used as a contrast agent
in photoacoustic tomography for the first time to our
knowledge. The ICG-PEG in phosphate buffered
saline (pH  7.4; concentration  3.2 3 1024 M) was
injected intravenously at a dosage of 0.25 ml100 g
body weight, which led to an estimated ICG con-
centration of 1 3 1025 M in the blood. With this
ICG-PEG dosage and the applied laser energy density
for this experiment, the magnitude of the photo-
acoustic signals received by the ultrasonic transducer
was of the order of 10 mV. Considering the 60-mm
resolution that has been achieved by this system (to
be reported elsewhere), the number of molecules in
the 60 mm 3 60 mm 3 60 mm resolvable volume is
2 fmol, which represents an underestimate of the
sensitivity of our imaging system.
By observing the changes in the intensity of the
photoacoustic signals from the brain vessels, we
studied the time-dependent variation of absorption
in the brain blood attributable to the contrast agent
[Fig. 1(C)]. The results represent the clearance pro-
file of the dye from the circulatory system of the rat,
where ICG-PEG shows an obviously slower clearance
than the native ICG.
Photoacoustic angiographs of rat brains in situ
based on either the intrinsic contrast or the ICG-PEG
enhanced contrast were compared. The contrast
between the large blood vessels and the background
tissue was approximately 1.8:1 without the contrast
agent. The contrast was enhanced to 2.8:1 by the
ICG-PEG at the applied dosage.
ICG-PEG was applied to noninvasive photoacoustic
angiography in the rat brain in vivo (Fig. 2). After
the experiment, the rat recovered normally without
noticeable health problems. Compared with the
reference image in Fig. 2(A), the image in Fig. 2(B),
obtained after the injection of ICG-PEG, represents
a clearer map of the brain vascular branches that
matches well with the photograph of the anatomy.
Figure 2(A) was subtracted from the image with
contrast enhancement in Fig. 2(B). The differen-
tial image in Fig. 2(C) depicts the distribution of
differential optical absorption in the rat brain that
is attributed to the injected contrast agent. This
subtraction reduces the background and further
enhances the contrast of blood vessels in rat brains.
Some detailed brain vascular structures that cannot
be visualized from the image in Fig. 2(B), such as the
small vessel branches identified by the black arrows
in the figure, were revealed by this differential image.
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in vivo, employing NIR light and an optical contrast agent
(ICG-PEG). (A), (B) Photoacoustic images acquired before
and after the injection of ICG-PEG, respectively, where
the two gray scales are the same. MF, median fissure.
(C) ICG-based angiograph of the rat brain (C  B 2 A).
(D) Open-skull photograph of the rat brain obtained after
the data acquisition for photoacoustic imaging.
More important, this experiment demonstrated the
potential of photoacoustic tomography for dynamic
and molecular imaging.
A circular scan of even an unfocused transducer was
able to produce high-quality images of the cerebral cor-
tex for the following reasons. Most large blood vessels
are distributed in the brain cortex. The photoacous-
tic signals that originated from the strong optical
absorption in the vasculature of the dorsal cerebral
cortex were dominant. Conversely, the photoacoustic
signals from the large vessels in the ventral brain
were relatively small because of the attenuation of
light in the brain. In addition, the aperture effect
of the ultrasonic transducer provided some resolution
along the z axis.
Images obtained with this setup represent a distri-
bution of the averaged optical absorption during the
data acquisition. In this case the applied contrast
agent with a prolonged clearance time benefits the
acquisition of imaging signals, especially when several
images need to be acquired with the current imag-
ing system after the intravascular injection. When
an ultrasonic transducer array, instead of a single-
element transducer, is adopted in the future, this
technology will provide real-time and more accuratequantitative monitoring of the brain hemodynamics.
Consequently, the clearance time will not need to
be prolonged in that case. The in vivo dynamics of
the exogenous dye can provide useful physiological
information.
In summary, angiography in the rat brain yielding
high contrast and high spatial resolution based on the
photoacoustic imaging of exogenous contrast agents
has been implemented noninvasively. This technique
provides an accurate noninvasive monitoring method
for f luid pathways in biological tissues, which makes
it a powerful method for imaging vascular changes in
tumors, delineating neovascularization, and studying
global and regional hemodynamic activities in the
brain. Since the contrast agent is expected to accumu-
late in neoplastic tissues or traumatized regions, this
technique is promising for determining the margins
of embedded tumors or bruises with a high degree
of accuracy. More important, since contrast agents
can be conjugated to bioactive peptides, proteins,
antibodies, hormones, drugs, or other bioactive agents,
this technique can be readily extended to molecular
and functional imaging. For example, with high-
frequency ultrasonic detection and tumor-targeted op-
tical contrast agents, this technique offers promise for
imaging pathologic processes at molecular and genetic
levels. All these objectives can be accomplished by
virtue of the high optical contrast and high ultrasonic
resolution that this technique provides.
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